Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Generic Fluticasone/Salmeterol vs Advair Diskus in Asthma
NCT02496715Phase 3Withdrawn
- Sponsor
- Allergan
- Start
- Sep 2015
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of fluticasone propionate, salmeterol in asthma, sponsored by Allergan. Planned start Sep 2015; status: withdrawn.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02496715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496715.